home / stock / elgx / elgx news


ELGX News and Press, Endologix Inc. From 02/24/20

Stock Information

Company Name: Endologix Inc.
Stock Symbol: ELGX
Market: NASDAQ
Website: endologix.com

Menu

ELGX ELGX Quote ELGX Short ELGX News ELGX Articles ELGX Message Board
Get ELGX Alerts

News, Short Squeeze, Breakout and More Instantly...

ELGX - Endologix Announces Debt Restructuring Addressing 2020 Maturities

Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into an exchange agreement with three holders of the Company’s 3.25% Senior Convertible...

ELGX - Endologix, Inc. (ELGX) CEO John Onopchenko on Q4 2019 Results - Earnings Call Transcript

Endologix, Inc. (ELGX) Q4 2019 Earnings Conference Call February 19, 2020 4:30 PM ET Company Participants John Onopchenko - Chief Executive Officer Vaseem Mahboob - Chief Financial Officer Matthew Thompson - Chief Medical Officer Conference Call Participants Allen Gong - J....

ELGX - Endologix, Inc. 2019 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Endologix, Inc. in conjunction with their 2019 Q4 earnings Read more ...

ELGX - Endologix EPS beats by $0.51, beats on revenue

Endologix (NASDAQ: ELGX ): Q4 GAAP EPS of -$0.40 beats by $0.51 . More news on: Endologix, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

ELGX - Endologix Reports Fourth Quarter and Fiscal Year 2019 Financial Results

Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019. Global revenue in the fourth quarter of 2019 was $35.8 mi...

ELGX - Endologix, Inc. to Present at the SVB Leerink Global Healthcare Conference

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer, will present at the 9 th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. ET on Wednesday, February 26, 2020 in Ne...

ELGX - Endologix sees Q4 revenue of ~$35.8M

On a preliminary basis , Endologix ( ELGX   -1% ) expects Q4 and 2019 revenues of ~$35.8M (consensus: $34.3M) and ~$143.4M (consensus: $142.1M), respectively. More news on: Endologix, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...

ELGX - Endologix Announces Preliminary Financial Results and Conference Call for Fourth Quarter and Full-Year 2019

Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the fourth quarter ended December 31, 2019 is expected to be approximately $35.8 million. Revenue fo...

ELGX - LK, NAV, WWE and ADNT among midday movers

Gainers:  Navistar International (NYSE: NAV ) +54% . More news on: Navistar International Corporation, Lianluo Smart Limited, Workhorse Group Inc., Stocks on the move, , Read more ...

ELGX - Endologix (ELGX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by Endologix, Inc. in conjunction with this Read more ...

Previous 10 Next 10